Eczema

A crosslinked polymer skin barrier film for moderate to severe atopic dermatitis

For patients with atopic dermatitis (AD), a comfortable, ...

Off-label use of dupilumab for pediatric patients with atopic dermatitis

Systemic treatments, like dupilumab, for pediatric patients with ...

Mental health impairment among children with atopic dermatitis

While it is known that atopic dermatitis (AD) ...

The proteomic skin prole of moderate-to-severe atopic dermatitis patients shows an inflammatory signature

This study sought to characterize the atopic dermatitis ...

Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis

Self-administered questionnaires and skin examinations were conducted to ...

Combining teledermatology with nonphysician members of the health care team to address access and compliance barriers in pediatric atopic dermatitis: A needs assessment

The attitudes and requirements of healthcare providers were ...

Conjunctivitis in patients with atopic dermatitis treated with dupilumab in a real-world setting

Conjunctivitis has been a known adverse event in ...

A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children

The Eczema Area and Severity Index (EASI) is ...

The effect of alcohol when taking dupilumab for atopic dermatitis

This case study reports repeated and clinically significant ...

Assessing the effectiveness of delgocitinib ointment on atopic dermatitis

A new topical Janus kinase inhibitor, delgocitinib ointment, ...